ASCO 25: AZ Pitches Upfront Oral SERD Use in Breast Cancer
Summary by Pharmaphorum
3 Articles
3 Articles
All
Left
Center
1
Right
The multinational pharmaceutical company AstraZeneca believes that the future of oncological research is to move away from a universal solution for patients and to anticipate resistance to treatment before it takes place, and in this line it has presented two clinical trials at the main congress of the sector. The entry AstraZeneca presents two trials with promising advances in breast and gastric cancer was first published in Digital Process.
Coverage Details
Total News Sources3
Leaning Left0Leaning Right0Center1Last UpdatedBias Distribution100% Center
Bias Distribution
- 100% of the sources are Center
100% Center
C 100%
Factuality
To view factuality data please Upgrade to Premium